BA
The Boeing Company
BA has the edge over CMBT overall, supported by stronger modeled upside and lower modeled downside.
CMBT
Cmb.Tech N.V.
CMBT trails on the overall score without a compensating advantage in the available component scores.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CMBT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Under pressure |
CMBT's revenue, profitability and cash flow are currently healthy, but its balance sheet is under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CMBT in the historical PE scenario, which offers more potential upside but is not a forecast.
CMBT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.9x | $8.29 | -53% |
| Current | 6.1x | $17.61 | — |
| Fair | 7.7x | $22.14 | +26% |
| Forward | 9.8x | $17.61 | — |
| Expensive | 18x | $50.69 | +188% |
Historical ranges are pointers, not guarantees.
CMBT's PE is in its fair range at 6.1x, but its recent earnings include one-off gains. Analysts expect earnings to fall, which would put today's price at 9.8x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over CMBT on the outlook, with more favorable earnings and revenue expectations.
CMBT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect CMBT's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over CMBT on earnings, with more consistent year-over-year improvement.
CMBT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.79 | -38% |
| Q2 2026 | $2.89 | +131% |
| Q1 2026 | $1.70 | -21% |
| Q4 2025 | $0.66 | -85% |
| Q3 2025 | $0.83 | -86% |
| Q2 2025 | $1.25 | -79% |
| Q1 2025 | $2.15 | -63% |
| Q4 2024 | $4.36 | +0.9% |
| Q3 2024 | $5.97 | +73% |
CMBT's earnings per share have fallen from their peak: $2.89 over the past year, against $6.02 in mid-2024. Its recent earnings include one-off gains.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CMBT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $691.4M | +78% |
| Q1 2026 | $519.6M | +121% |
| Q4 2025 | $589M | +161% |
| Q3 2025 | $454.2M | +105% |
| Q2 2025 | $387.8M | +55% |
| Q1 2025 | $235M | -1.6% |
| Q4 2024 | $226M | -19% |
| Q3 2024 | $221.8M | -18% |
CMBT's revenue is recovering but still below its 2020 peak: $691M last quarter, up 78% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 41% | +25 points |
| Q1 2026 | 33% | -11 points |
| Q4 2025 | 28% | -33 points |
| Q3 2025 | 28% | -33 points |
| Q2 2025 | 15% | -71 points |
| Q1 2025 | 44% | +4.3 points |
| Q4 2024 | 61% | +23 points |
| Q3 2024 | 62% | +20 points |
CMBT has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over CMBT on cash flow, with more consistent year-over-year improvement.
CMBT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $249.9M | +$542.3M |
| Q1 2026 | $167.4M | +$364.9M |
| Q4 2025 | $11.7M | +$322M |
| Q3 2025 | -$133.8M | +$26.4M |
| Q2 2025 | -$292.4M | -$28.1M |
| Q1 2025 | -$197.6M | -330% |
| Q4 2024 | -$310.3M | -262% |
| Q3 2024 | -$160.2M | -280% |
CMBT's free cash flow has turned positive again: $295M over the past year, against −$960M the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has the edge over CMBT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CMBT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +49% | +96M shares |
| 3 years | +44% | +88.3M shares |
| 5 years | +38% | +80M shares |
| Available history | +83% | +132M shares |
CMBT has 290M diluted shares, up 49% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $572,205 |
| Q3 2024 | $716,108 |
CMBT hasn't bought back shares in the past year.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA has the edge over CMBT on leverage, with a lower net debt burden relative to earnings.
CMBT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.0x | Elevated |
| Q1 2026 | 4.4x | High |
| Q4 2025 | 6.3x | High |
| Q3 2025 | 7.3x | High |
| Q2 2025 | 7.3x | High |
| Q1 2025 | 6.6x | High |
| Q4 2024 | 2.2x | Moderate |
| Q3 2024 | 2.0x | Healthy |
CMBT's net debt is about 4.0 years of its operating earnings (EBITDA), down from 7.3 years a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CMBT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.6 | Neutral |
| Stochastic | 33.0 | Neutral |
CMBT's weekly RSI is 53 (neutral) and its Stochastic is 33 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
CMBT PE vs Industrials Sector
| Metric | CMBT | Sector median | Relative |
|---|---|---|---|
| PE | 6.1x | 24x | 75% below |
| PE % | 45 | 58 | 13 pts below |
CMBT has the edge over BA on valuation relative to its sector.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CMBT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.5 | 4.7% below |
| 20 week MA | $17.7 | 0.5% below |
| 50 week MA | $14.8 | 19% above |
| 100 week MA | $12.2 | 45% above |
| 200 week MA | $14.3 | 23% above |
CMBT has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CMBT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.2 | $8.08 | -34% |
| 2021 | $8.08 | $8.81 | +9% |
| 2022 | $8.81 | $17.2 | +96% |
| 2023 | $17.2 | $17.6 | +2% |
| 2024 | $17.6 | $10.0 | -43% |
| 2025 | $10.0 | $9.70 | -3.3% |
| 2026 YTD | $9.70 | $17.6 | +82% |
CMBT has the edge over BA on returns for 2026, with the stronger performance.